NEW
YORK, July 25, 2024 /PRNewswire/ -- The
global bio-detection market size is estimated to grow by
USD 16.84 billion from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of 15.2% during the forecast period. Increasing incidence of
infectious disease and cancer is driving market
growth, with a trend towards increasing applications of
microorganisms. However, inadequate healthcare services in
developing regions poses a challenge. Key market players include
20/20 GeneSystems Inc., 3M Co.,
Abbott Laboratories, AdVnt Biotechnologies LLC, Agilent
Technologies Inc., Alexeter Technologies LLC, Bertin Technologies
SAS, Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp., F.
Hoffmann La Roche Ltd., Illumina Inc., MBio Diagnostics Inc.,
Physical Sciences Inc., PositiveID Corp., Research International
Inc., Response Biomedical Corp., Sense Biodetection Inc, Smiths
Group Plc, and Thermo Fisher Scientific Inc..
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Bio-Detection Market
Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
15.2%
|
Market growth
2024-2028
|
USD 16848.8
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
12.86
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
41%
|
Key
countries
|
US, China, Germany,
Canada, and UK
|
Key companies
profiled
|
20/20 GeneSystems Inc.,
3M Co., Abbott Laboratories, AdVnt Biotechnologies LLC, Agilent
Technologies Inc., Alexeter Technologies LLC, Bertin Technologies
SAS, Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp., F.
Hoffmann La Roche Ltd., Illumina Inc., MBio Diagnostics Inc.,
Physical Sciences Inc., PositiveID Corp., Research International
Inc., Response Biomedical Corp., Sense Biodetection Inc, Smiths
Group Plc, and Thermo Fisher Scientific Inc.
|
Market Driver
The bio-detection market is experiencing significant growth due
to the increasing use of microorganisms in the production of
various commercial products. Microorganisms are utilized in the
production of food items and beverages, food additives and
supplements, and microbial enzymes. Industrial microbiologists
carry out activities such as microorganism isolation, product
screening, culture maintenance, and product retrieval and
purification for these commercial applications. Microorganisms are
used to produce beverages like beer, wine, whiskey, brandy, and rum
through fermentation. For instance, Saccharomyces cerevisiae is
used to ferment fruit juices and malted cereals to produce ethanol.
In the food industry, microorganisms help produce amino acids such
as lysine and glutamic acid, used as nutritional supplements in
bread products. Microorganisms also play a crucial role in the
commercial production of enzymes like cellulase, lipase, amylase,
protease, and pectinase, which are widely used in food preservation
and processing. Additionally, microorganisms are used to
commercialize certain organic acids, such as citric acid, acetic
acid, and lactic acid, produced by Aspergillus Niger and
Lactobacillus. Given the rising demand for microorganism-derived
products, the global bio-detection market is anticipated to grow
substantially during the forecast period. Bio-detection products
such as microbial identification systems, kits, and reagents are
essential for the various activities involved in producing these
commercial products from microorganisms.
The Bio-Detection Market is experiencing significant growth due
to rising concerns over bio-terrorism and various illnesses causing
deaths. Biological weapons such as ricin letters and potential
pathogens like H1N1 and Ebola require advanced biodetection systems
for early warning. Healthcare systems are increasing their
bio-surveillance budgets to ensure quick bio-attack alarm times.
Sensitivity and selectivity are crucial factors in biodetection,
with acute stress, genotoxicity, obesity, and reproductive toxicity
being key areas of focus. Biodetection technologies are also used
for bioanalyses and chemical analyses in defense, food and
environment, clinical, and gene sequencing processes. Agilent
Technologies offer solutions through DNA-based assays, calibration
standards, and regulatory policies. Safety standards are essential
in handling contaminants, compound classes, mixtures, and accessory
and consumable production. Government support drives research and
development in biodetection technologies for medications against
viruses and other pathogens, airborne chemicals, and biological
warfare.
Discover 360° analysis of this market. For
complete information, schedule your consultation - Book
Here!
Market Challenges
- Developing countries face significant challenges in providing
access to healthcare services, including a lack of knowledge and
resources for disease prevention, limited financial means, and
insufficient infrastructure. These issues contribute to the
prevalence of infectious diseases, which poses a major public
health concern. Countries such as Afghanistan and Bangladesh struggle with outdated technology
and inadequate policies for delivering healthcare services. The
stigma surrounding conditions like sexually transmitted diseases
(STDs) further discourages testing and treatment. These challenges,
including high mortality and morbidity rates, a shortage of skilled
healthcare personnel, and inadequate healthcare systems, will
hinder the expansion of the global bio-detection market during the
forecast period.
- The Bio-Detection Market is experiencing significant growth due
to the increasing demand for faster and more accurate
identification of biological agents. Two key technologies leading
the way are microfluidics-based biodetectors and
electrochemiluminescence-based biodetectors, which offer faster
reaction times and the ability to recognize multiple agents.
However, challenges remain in detecting low-level agents and
achieving lower detection limits. In various sectors, such as
healthcare organizations, counter-terrorism, and homeland security,
there is a strong presence of biodetection technology. This
technology is crucial in addressing threats from anthrax pathogens,
air pollution, and chronic diseases, as well as contact illnesses
and biosecurity risks. Outsourcing activities and biothreat
response teams rely on biodetection instruments like pathogen
testing equipment, biosensor-based systems, gas analyzers, and
PCD-based assays. Biodetection technology plays a vital role in
various applications, including DNA analysis, biomarker
identification, illicit drugs, poisons, and defense segment. With
the increasing threat of bioattacks and biological agents,
next-generation sequencing devices and reagents and media have
become essential components of biodetection equipment. The market
for biodetection technology is expected to grow further due to the
rising bioterrorism threat levels and pathogen outbreaks.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This bio-detection market report extensively covers market
segmentation by
- Application
- 1.1 Clinical
- 1.2 Food and environmental
- 1.3 Defense
- Product
- 2.1 Instruments
- 2.2 Accessories and consumables
- 2.3 Reagents and media
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Clinical- The clinical segment dominated the global
bio-detection market in 2023 due to rising demand from critically
ill patients post-pandemic and an aging population. Additionally,
the increase in infectious diseases such as influenza and measles
in developed and developing countries drives the demand for
bio-detection in clinics. However, the preference for POCT
(point-of-care testing) may hinder the growth of this segment
during the forecast period.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data
(2017-2021) - Download a Sample Report
Learn and explore more about Technavio's in-depth research
reports
The global High Throughput Screening (HTS) market is set for
significant growth, driven by advancements in drug discovery and
personalized medicine. The Toxicology Testing market is expanding
as regulatory demands increase and the need for safety assessments
in pharmaceuticals and chemicals rises. Meanwhile, the global
In-vitro Diagnostics market is thriving due to the increasing
prevalence of chronic diseases and advancements in diagnostic
technologies. Together, these sectors reflect a robust trend
towards enhanced precision and efficiency in medical and
pharmaceutical research.
Research Analysis
The Bio-Detection Market encompasses a range of technologies and
instruments designed to identify and detect various illnesses,
including airborne diseases, arsenicosis, cancer, chronic kidney
disease, and cardiovascular disease. With growing concerns over
environmental degradation and the increasing threat of
bioterrorism, the demand for advanced biodetection systems has
surged. These systems play a crucial role in detecting potential
pathogens, such as viruses, bacteria, and biological weapons,
including ricin letters and anthrax. The market is driven by
clinical urgency, government support, and public awareness
campaigns. Bio-detection technologies have proven instrumental in
mitigating the impact of outbreaks, such as H1N1 attacks, Ebola
outbreaks, and airborne chemicals. The market is expected to grow
significantly, with increasing bio-surveillance budgets and the
development of more sophisticated biodetection instruments.
Market Research Overview
The Bio-Detection Market encompasses technologies and
instruments used for identifying and detecting various harmful
organisms, including airborne diseases such as tuberculosis and
anthrax, as well as environmental contaminants like arsenicosis and
heavy metals. This market is driven by the growing awareness of
environmental degradation and the potential health risks it poses,
as well as the threat of bioterrorism and bioweapons. Biodetection
technologies include biosensors, microarrays, microfluidics-based
biodetectors, and electrochemiluminescence-based biodetectors,
which offer faster reaction times and the ability to detect
multiple agents simultaneously. The market has a strong presence in
healthcare organizations, clinical segments, and the medical field,
with applications in pathogen testing, drug toxicology research,
and bioterrorism threat levels. Biodetection equipment includes
pathogen testing equipment, biosensor-based systems, gas analyzers,
and next-generation sequencing devices. The market also caters to
the defense segment, with applications in counter-terrorism and
homeland security. The market is witnessing a surge in demand due
to the increasing number of chronic diseases, contact illnesses,
and potential pathogens, including minute viruses and hazardous
biological weapons. The market is expected to grow significantly
due to the increasing bio-surveillance budgets, rapid diagnostic
kits, and the need for biothreat response. The market also includes
reagents and media, PPE, and biodefense systems, with a focus on
low-level detection capability and sensitivity and selectivity for
various applications. The market is also witnessing a trend towards
outsourcing activities for biodetection services. The market faces
challenges such as detection limits, biothreat response, and the
need for faster reaction times. The market includes key
applications such as H1N1 attacks, Ebola outbreaks, Ricin letters,
and other bioterrorism incidents. The market also includes
potential pathogens such as viruses, bacteria, and toxins, and
various illnesses and deaths caused by these agents. The market is
expected to grow significantly due to the increasing awareness of
biosecurity and the potential consequences of bio-attacks. The
market also includes various regulatory frameworks and
certifications, such as FDA approval and CE marking, which ensure
the safety and efficacy of biodetection instruments and reagents.
The market also includes various trends such as the integration of
artificial intelligence and machine learning algorithms for faster
and more accurate detection, and the development of portable and
wearable biodetection devices for real-time monitoring. The market
also includes various challenges such as the high cost of
biodetection instruments and the need for continuous innovation to
keep up with emerging threats. The market is expected to grow
significantly in the coming years due to the increasing demand for
rapid and accurate biodetection systems and the need to mitigate
the risks of bioterrorism and other biological threats.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Application
-
- Clinical
- Food And Environmental
- Defense
- Product
-
- Instruments
- Accessories And Consumables
- Reagents And Media
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-detection-market-size-is-set-to-grow-by-usd-16-84-billion-from-2024-2028--increasing-incidence-of-infectious-disease-and-cancer-boost-the-market-technavio-302205414.html
SOURCE Technavio